The following information is provided to satisfy virtual marking requirements of various jurisdictions including Section 287(a) of Title 35 of the United States Code and to provide notice of patent rights of Astrea UK Services Limited.

Astrea Bioseparations products are covered by or for use under one or more of the following U.S. patents and other country patents. Other patents pending.

Product Patents
EtoxiClear® US 8,765,393
Evolve®Patent Pending PCT application PCT/GB2023/051209
Fabsorbent™US 8,076,477
HCPure™Patent Pending UK application 2218303.2
Nanofiber membrane separation technology and devices, including Nereus® EP 2,959,509; US 9,604,168; US 10,293,289; US 10,919,986; US 11,466,386; US11,506,438
Purabead® Patent Pending UK application 2113284
SNAP® US 7,901,574; US 8,318,010

Last updated: 6 June 2023